Rights and permissions
About this article
Cite this article
IV THEOPHYLLINE: FDA DOSAGE GUIDELINES CRITICIZED. Inpharma Wkly. 258, 3 (1980). https://doi.org/10.1007/BF03317387
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03317387
This is a preview of subscription content, log in via an institution to check access.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Rent this article via DeepDyve
IV THEOPHYLLINE: FDA DOSAGE GUIDELINES CRITICIZED. Inpharma Wkly. 258, 3 (1980). https://doi.org/10.1007/BF03317387
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03317387
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative